Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Nel ASA Secures EU Backing for Next-Generation Hydrogen Technology

Dieter Jaworski by Dieter Jaworski
December 13, 2025
in Analysis, European Markets, Hydrogen, Renewable Energy, Turnaround
0
Nel ASA Stock
0
SHARES
70
VIEWS
Share on FacebookShare on Twitter

Norwegian hydrogen specialist Nel ASA has reached a pivotal strategic milestone. After seven years in development, the company’s board has given the final investment decision to construct up to one gigawatt of production capacity for its new electrolyzer platform. The move, announced Friday and supported by substantial European Union funding, aims to drastically improve the efficiency and economics of hydrogen production. The critical question for investors is whether this technological leap can provide a lasting foundation for the company’s recently volatile share price.

Financial Momentum and Market Reaction

The market’s initial response to the news was positive, with Nel’s shares advancing over 4% to 2.38 NOK. Central to the announcement is the commercialization of the firm’s “Next Generation Pressurized Alkaline” (NGP) systems. A key enabler for the project is financial support from the European Union’s Innovation Fund, which has committed grants covering up to 60% of relevant capital and operational expenditures, amounting to as much as 135 million euros. This commitment has triggered an immediate first disbursement of over 10 million euros.

CEO Håkon Volldal emphasized that the NGP technology is designed to reduce hydrogen costs to a level where business models can achieve profitability without relying heavily on subsidies.

Operational Challenges Amid Strategic Progress

This strategic shift comes against a backdrop of mixed operational results. Nel’s third-quarter report showed a 17% year-over-year revenue decline to 303 million Norwegian kroner. However, the company managed to significantly narrow its EBITDA loss, which improved from 90 million NOK to 37 million NOK.

Despite the recent quarterly revenue weakness, new business activity has been robust. In November alone, Nel secured an order worth more than $50 million for two 20-megawatt electrolyzer plants in Norway, marking the second-largest firm order in its history. The company’s order backlog remained solid at 984 million NOK as of the end of September.

Should investors sell immediately? Or is it worth buying Nel ASA?

Technological Advancements and Potential Write-Downs

The new technology represents a radical simplification in system design. It utilizes a modular, skid-based approach where fully assembled and pre-tested containerized units are delivered, eliminating complex on-site construction for customers and allowing for outdoor installation.

This progress, however, carries a potential financial implication for the balance sheet. Because the new pressurized technology is expected to be significantly more cost-effective, management is reviewing the book value of its existing, currently idled production lines for atmospheric alkaline electrolyzers. Investors may need to prepare for potential asset impairments as these older lines risk becoming obsolete.

Analyst Caution and the Road Ahead

The commercial launch for the new technology platform is scheduled for the first half of 2026, with scaling operations expected to follow in 2027. While the recent developments are positive, analyst sentiment remains cautious. The prevailing market consensus recommendation continues to be predominantly “Underweight,” although some institutions, including Citi, have modestly raised their price targets—Citi’s now stands at 2.70 NOK.

Further clarity on the financial trajectory will likely come with Nel’s fourth-quarter results, scheduled for release in late February 2026. Until then, the investment thesis for the stock hinges largely on the new platform’s ability to deliver its promised substantial reductions in the cost of hydrogen.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from August 7 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 7.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

August 7, 2026
SANDISK Stock
Analysis

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
FALLBACK Stock
Analysis

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026
Next Post
XRP Stock

XRP's Pivotal Battle at the $2 Threshold

Boeing Stock

Boeing's Order Surge Faces Regulatory Hurdles

Adobe Stock

Adobe's AI Ambitions Come at a Cost to Profitability

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com